» Articles » PMID: 3699894

Inhibition of Macrophage Phagocytosis by Bacteroides Fragilis in Vivo and in Vitro

Overview
Journal Infect Immun
Date 1986 May 1
PMID 3699894
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A number of investigators have provided experimental evidence for synergistic effects in mixed infections with Escherichia coli and Bacteroides fragilis. In vitro studies have suggested that competition for serum opsonins and diminished subsequent phagocytosis by polymorphonuclear leukocytes might explain these effects. In the present study we evaluated the effect of B. fragilis on macrophage phagocytosis. It was shown that peritoneal macrophages from mice injected intravenously 6 to 12 h earlier with 10(8) CFU of encapsulated B. fragilis were markedly suppressed in their phagocytic ability. Injections of laboratory-passaged, less-encapsulated B. fragilis, other bacteria, or latex particles were either not suppressive of macrophage phagocytosis or less effective. When peritoneal macrophages were treated in vitro for 24 h with the same challenge organisms prior to assessing their phagocytic capacity, encapsulated B. fragilis also proved significantly more suppressive than challenges with other organisms or latex particles. We conclude that suppression of macrophage phagocytosis by B. fragilis seems to be an important mechanism contributing to synergistic effects described for mixed aerobic and anaerobic infections.

Citing Articles

Gut species in health and disease.

Zafar H, Saier Jr M Gut Microbes. 2021; 13(1):1-20.

PMID: 33535896 PMC: 7872030. DOI: 10.1080/19490976.2020.1848158.


Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.

Subramanian S, Roberts C, Hart C, Martin H, Edwards S, Rhodes J Antimicrob Agents Chemother. 2007; 52(2):427-34.

PMID: 18070962 PMC: 2224732. DOI: 10.1128/AAC.00375-07.


Induction of an atypical interferon by bacteroides fragilis and Escherichia coli in experimental infections and in leukocyte cultures.

Blanchard D, Rodloff A, Steward 2nd W, Hahn H, Friedman H Infection. 1986; 14(6):289-93.

PMID: 2434431 DOI: 10.1007/BF01643965.

References
1.
Onderdonk A, Bartlett J, Louie T, Gorbach S . Microbial synergy in experimental intra-abdominal abscess. Infect Immun. 1976; 13(1):22-6. PMC: 420571. DOI: 10.1128/iai.13.1.22-26.1976. View

2.
Dijkmans B, Leijh P, Braat A, Van Furth R . Effect of bacterial competition on the opsonization, phagocytosis, and intracellular killing of microorganisms by granulocytes. Infect Immun. 1985; 49(1):219-24. PMC: 262082. DOI: 10.1128/iai.49.1.219-224.1985. View

3.
Ingham H, Sisson P, Tharagonnet D, Selkon J, Codd A . Inhibition of phagocytosis in vitro by obligate anaerobes. Lancet. 1977; 2(8051):1252-4. DOI: 10.1016/s0140-6736(77)92662-9. View

4.
Kelly M . The quantitative and histological demonstration of pathogenic synergy between Escherichia coli and Bacteroides fragilis in guinea-pig wounds. J Med Microbiol. 1978; 11(4):513-23. DOI: 10.1099/00222615-11-4-513. View

5.
Kasper D, Onderdonk A, Crabb J, Bartlett J . Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J Infect Dis. 1979; 140(5):724-31. DOI: 10.1093/infdis/140.5.724. View